Milestone Pharmaceuticals Inc.
MIST· Nasdaq
Released Mar 20, 2026, before the open
10-K filed Mar 20, 2026, 79 days after period end · 0001104659-26-032415
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$17.41M | -$12.36M | -$13.61M | -$13.18M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2025 · filed Mar 20, 2026 · 79 d after period end
19.7% from the close of Mar 19, 2026 to the close of Mar 20, 2026, the first after the release.